Yüklüyor......
Ribociclib-Induced Pneumonitis: A Case Report
BACKGROUND: Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have been a significant breakthrough in the management of hormone receptor-positive, HER2-negative metastatic breast cancer based on the results of several large phase III randomized trials. The most common reported toxicity is myelosuppre...
Kaydedildi:
| Yayımlandı: | Breast Care (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248782/ https://ncbi.nlm.nih.gov/pubmed/34248473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507647 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|